Opioids Market Overview

An overview of conceptual frameworks, analytical approaches of the Opioids market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Opioids market is expected to grow with significant rate in the near future.

The global Opioids Market in 2020 is estimated for more than US$ 19.5 Bn and expected to reach a value of US$ 26.3 Bn by 2028 with a significant CAGR of 3.9%.

Opioids Market Definition

Pain is the major concern currently that is affecting a large chunk of the global population and eventually leading to adopt various drug therapies that have numerous side effects on the body. Opioids in this are helpful though they have a tendency to trigger addiction of its products that had forced the government to keep an eye on their manufacturing and selling.

In 2013, according to The American Academy of Pain Medicine, around 100 Mn people were suffering from pain, which costs around half Tn USD. In past, there had been visible changes in the policies of various healthcare professionals, regulators and public that has positively affected the provision of better pain therapy offerings in the country. Centers for Disease Control and Prevention (CDC) has taken initiatives and provided the customers with a set of guidelines, which possibly be effective for better use of the opioids in the market over the forecast period.

Opioids Market Dynamics

The rapid need of treatment and attaining instant relief are the two major factors that are expected to favor the growth in the opioids market in the near future. Due to the enormous increase in the number of emergency situations along with chronic diseases there has been increasing demand for more types of opioids that help in pain relief. Along with the increase in healthcare facilities and increase in research and development activity in the field of pain management the awareness of the positive effects of opioids has been increased that is expected to support the rise in traction in opioids market in the near future.

Opioids Market Key Players

Global opioids market is mainly dominated by:

Pfizer Inc.

Purdue Pharma

Boehringer Ingelheim

Janssen Pharmaceuticals, Inc.

Actavis Plc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Mallinckrodt Pharmaceuticals

Endo Pharmaceuticals Inc.

Egalet

Opioids Market Segmentation

The global opioids market is segmented on the basis of product type, application type, and region

On the basis of product type, the global opioids market can be segmented into:

Codeine

Meperidine

Methadone

Morphine

Hydrocodone

Fentanyl

On the basis of therapeutic application, the global opioids market can be segmented into:

Pain Management

Neuropathic Pain

Migraine

Back Pain

Osteoarthritis Pain

Cancer Pain

Others

Cough Treatment

Diarrhea Treatment

The global opioids market is expected to increase at a significant CAGR over the forecast period owing to the increasing chronic diseases, geriatric population and increase in trend for immediate relief across the healthcare receivers.

Opioids Market Regional Segmentation Overview

On the basis of region, the global opioids market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America opioids market is expected to be the most dominating market throughout the forecast period. Availability of key players and increasing healthcare expenditure in the region are some of the revenue boosting factors.

MMC Overview on Opioids Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Opioids market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Opioids Market: Opportunity Analysis and Future Assessment 2020-2028’.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Opioids

•    Advantages of Opioids

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Opioids Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Opioids Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Opioids Market Snapshot

2.4.    Global Opioids Market Size and Forecast, 2019–2027

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)

2.5.    Global Opioids Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Opioids Market, By Product Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product Type

3.1.2.    BPS Analysis, By Product Type

3.2.    Market Revenue (US$Mn) Forecast, By Product Type

3.2.1.    Codeine

3.2.2.    Fentanyl

3.2.3.    Meperidine

3.2.4.    Methadone

3.2.5.    Morphine

3.2.6.    Hydrocodone

3.3.     Global Opioids Market Attractiveness Index, By Product Type

4.    Global Opioids Market, By Therapeutic Application

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Therapeutic Application

4.1.2.    BPS Analysis, By Therapeutic Application

4.2.    Market Revenue (US$Mn) Forecast, By Therapeutic Application

4.2.1.    Pain Management

4.2.1.1.    Neuropathic Pain

4.2.1.2.    Migraine

4.2.1.3.    Back Pain

4.2.1.4.    Osteoarthritis Pain

4.2.1.5.    Cancer Pain

4.2.1.6.    Others

4.2.2.    Cough Treatment

4.2.3.    Diarrhea Treatment

4.3.     Global Opioids Market Attractiveness Index, By Therapeutic Application

5.    Global Opioids Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East

5.2.6.    Africa

5.3.    Global Opioids Market Attractiveness Index, By Region

6.    North America Opioids Market Analysis and Forecast, 2019–2027

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Opioids Market

6.2.2.    Canada Opioids Market

6.3.    North America Opioids Market, By Product Type

6.3.1.    Codeine

6.3.2.    Fentanyl

6.3.3.    Meperidine

6.3.4.    Methadone

6.3.5.    Morphine

6.3.6.    Hydrocodone

6.4.    North America Opioids Market, By Therapeutic Application

6.4.1.    Pain Management

6.4.1.1.    Neuropathic Pain

6.4.1.2.    Migraine

6.4.1.3.    Back Pain

6.4.1.4.    Osteoarthritis Pain

6.4.1.5.    Cancer Pain

6.4.1.6.    Others

6.4.2.    Cough Treatment

6.4.3.    Diarrhea Treatment

6.5.    North America Opioids Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Product Type

6.5.3.    By Therapeutic Application

7.    Latin America Opioids Market Analysis and Forecast, 2019–2027

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    Brazil Opioids Market

7.2.2.    Mexico Opioids Market

7.2.3.    Argentina Opioids Market

7.2.4.    Rest of Latin America Opioids Market

7.3.    Latin America Opioids Market, By Product Type

7.3.1.    Codeine

7.3.2.    Fentanyl

7.3.3.    Meperidine

7.3.4.    Methadone

7.3.5.    Morphine

7.3.6.    Hydrocodone

7.4.    Latin America Opioids Market, By Therapeutic Application

7.4.1.    Pain Management

7.4.1.1.    Neuropathic Pain

7.4.1.2.    Migraine

7.4.1.3.    Back Pain

7.4.1.4.    Osteoarthritis Pain

7.4.1.5.    Cancer Pain

7.4.1.6.    Others

7.4.2.    Cough Treatment

7.4.3.    Diarrhea Treatment

7.5.    Latin America Opioids Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Product Type

7.5.3.    By Therapeutic Application

8.    Europe Opioids Market Analysis and Forecast, 2019–2027

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    U.K. Opioids Market

8.2.2.    Germany Opioids Market

8.2.3.    Italy Opioids Market

8.2.4.    France Opioids Market

8.2.5.    Spain Opioids Market

8.2.6.    Russia Opioids Market

8.2.7.    Poland Opioids Market

8.2.8.    BENELUX Opioids Market

8.2.9.    NORDIC Opioids Market

8.2.10.    Rest of Europe Opioids Market

8.3.    Europe Opioids Market, By Product Type

8.3.1.    Codeine

8.3.2.    Fentanyl

8.3.3.    Meperidine

8.3.4.    Methadone

8.3.5.    Morphine

8.3.6.    Hydrocodone

8.4.    Europe Opioids Market, By Therapeutic Application

8.4.1.    Pain Management

8.4.1.1.    Neuropathic Pain

8.4.1.2.    Migraine

8.4.1.3.    Back Pain

8.4.1.4.    Osteoarthritis Pain

8.4.1.5.    Cancer Pain

8.4.1.6.    Others

8.4.2.    Cough Treatment

8.4.3.    Diarrhea Treatment

8.5.    Europe Opioids Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Product Type

8.5.3.    By Therapeutic Application

9.    Asia Pacific Opioids Market Analysis and Forecast, 2019–2027

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    China Opioids Market

9.2.2.    India Opioids Market

9.2.3.    Japan Opioids Market

9.2.4.    Australia and New Zealand Opioids Market

9.2.5.    South Korea Opioids Market

9.2.6.    ASEAN Opioids Market

9.2.7.    Rest of Asia Pacific Opioids Market

9.3.    Asia Pacific Opioids Market, By Product Type

9.3.1.    Codeine

9.3.2.    Fentanyl

9.3.3.    Meperidine

9.3.4.    Methadone

9.3.5.    Morphine

9.3.6.    Hydrocodone

9.4.    Asia Pacific Opioids Market, By Therapeutic Application

9.4.1.    Pain Management

9.4.1.1.    Neuropathic Pain

9.4.1.2.    Migraine

9.4.1.3.    Back Pain

9.4.1.4.    Osteoarthritis Pain

9.4.1.5.    Cancer Pain

9.4.1.6.    Others

9.4.2.    Cough Treatment

9.4.3.    Diarrhea Treatment

9.5.    Asia Pacific Opioids Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Product Type

9.5.3.    By Therapeutic Application

10.    Middle East Opioids Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Opioids Market

10.2.2.    Israel Opioids Market

10.2.3.    Oman Opioids Market

10.2.4.    Rest of Middle East Opioids Market

10.3.    Middle East Opioids Market, By Product Type

10.3.1.    Codeine

10.3.2.    Fentanyl

10.3.3.    Meperidine

10.3.4.    Methadone

10.3.5.    Morphine

10.3.6.    Hydrocodone

10.4.    Middle East Opioids Market, By Therapeutic Application

10.4.1.    Pain Management

10.4.1.1.    Neuropathic Pain

10.4.1.2.    Migraine

10.4.1.3.    Back Pain

10.4.1.4.    Osteoarthritis Pain

10.4.1.5.    Cancer Pain

10.4.1.6.    Others

10.4.2.    Cough Treatment

10.4.3.    Diarrhea Treatment

10.5.    Middle East Opioids Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Product Type

10.5.3.    By Therapeutic Application

11.    Africa Opioids Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    South Africa Opioids Market

11.2.2.    Egypt Opioids Market

11.2.3.    North Africa Opioids Market

11.2.4.    Rest of Africa Opioids Market

11.3.    Africa Opioids Market, By Product Type

11.3.1.    Codeine

11.3.2.    Fentanyl

11.3.3.    Meperidine

11.3.4.    Methadone

11.3.5.    Morphine

11.3.6.    Hydrocodone

11.4.    Africa Opioids Market, By Therapeutic Application

11.4.1.    Pain Management

11.4.1.1.    Neuropathic Pain

11.4.1.2.    Migraine

11.4.1.3.    Back Pain

11.4.1.4.    Osteoarthritis Pain

11.4.1.5.    Cancer Pain

11.4.1.6.    Others

11.4.2.    Cough Treatment

11.4.3.    Diarrhea Treatment

11.5.    Africa Opioids Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Product Type

11.5.3.    By Therapeutic Application

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Pfizer Inc.

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Purdue Pharma

13.3.3.    Boehringer Ingelheim

13.3.4.    Janssen Pharmaceuticals, Inc.

13.3.5.    Actavis Plc.

13.3.6.    Sanofi

13.3.7.    Sun Pharmaceutical Industries Ltd.

13.3.8.    Mallinckrodt Pharmaceuticals

13.3.9.    Endo Pharmaceuticals Inc.

13.3.10.    Egalet

14.    Acronyms